Retreating Arrowhead axes CSO in RNAi rout; Impel raises $36M for platform tech
Now that Arrowhead $ARWR has decided to chop out everything it has in the clinic, along with about a third of its staff, the biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
